An open-label phase 1 study to investigate SGN-CEACAM5C in adults with advanced solid tumors
Details
Age
Adult
Type of Study
Treatment
Locations
University of Colorado Hospital
Principal Investigator
Sarah Davis, MD
Study ID
Protocol Number: 23-2329
More information available at ClinicalTrials.gov: NCT06131840
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers